Waarom die bloemkool? Bijgedragen aan het inspirerende contextprogramma bij de voorstelling Zenuwslopend van Ilse Oostvogels Parktheater. Deze voorstelling is een aanrader voor iedereen met interesse in MS, zie: ilseoostvogels.com/zenuwslopend. #erasms erasms.nl

Team #ErasMS looks back to a great ISNI 2021 meeting! We contributed to the online program, and look forward to live scientific interaction with our collegues! #ISNI2021 #weareneuroimmunology #erasms erasms.nl

The Dordrecht city run was cancelled due to COVID-19, but team ErasMS ran 10km to support the SPIN-P study on primary progressive MS! ErasMS.nl #multiplesclerosis

Just visited with the lab of team #Erasms the spectacular new depot Museum Boijmans Van Beuningen in front of our hospital #erasmusmc Gemeente Rotterdam. Highly recommended!

REGEN-COV is beschikbaar voor patiënten van #Erasms met hoog risico op afwezige antistoffen na COVID-19 vaccinatie én een ernstig COVID-19 verloop. Check voor details erasms.nl/bericht-voor-p…

Team #ErasMS excited to open the online MS research days 2021! Great program empowering the Dutch MS research community with MS Research, MS Centrum Amsterdam, Hersenbank, MS centrum Noord Nederland, Nieuw Unicum, Hasselt and many others!

Team MS center #ErasMS wishes you health and happiness in the new year! erasms.nl

Donate to Stichting Klimmen tegen MS klimmentegenms.moves.ms/team/erasms?ut… #Team #ErasMS will join all dedicated participants in the climbing of Mont Ventoux with Stichting MOVES to raise money for MS research. Do you support us and the MS community?

When soccer meets MS! Attending the Dutch Neurology Association meeting on MS with great talks on RIS (Kees Okkersen, Jeroen van Eijk), digital biomarkers (Ka-hoo Lam) and MS mimics (Judith van Everdingen).

The deadline to submit your abstract for #ECTRIMS2022 is just around the corner. Use this week to complete your research, submit your innovative work & become part of an outstanding scientific programme. ⏱️ Deadline: 18 May 2022 Apply today ➡️ bit.ly/36vheSm

Team ErasMS is going to drive 1000km in an old VW to climb Mont Ventoux next weekend to raise money for #MultipleSclerosis research. Please support us at klimmentegenms.moves.ms/team/erasms! Read the post of Joost@ErasMS at linkedin.com/posts/joostsmo…

Yes, reached the summit of Mont Ventoux with MoveS, team #ErasMS and team #NHB! Touched and inspired by the stories of all participants with and without #MS and proud of the team. Back to work now! Joost@ErasMS

There’s no exit strategy for pwMS on anti-CD20 atm. Some argue there’s no need to exit, some argue to extend intervals and we argue to stop anti-CD20 after 4 infusion cycli. Do you agree? journals.sagepub.com/doi/10.1177/13… MS center ErasMS

Multiple sclerose onderzoekers kunnen zich tot 11 september 2022 aanmelden als kandidaat voor de Rogier Hintzen Talent Award 2022! Zie voor meer info erasms.nl/nieuws/

Een nieuwe generatie MS behandeling komt eraan, maar hoe werken deze BTK-remmers eigenlijk? Team #ErasMS zocht het uit. Zie: erasms.nl/nieuws/

Rituximab (anti-CD20) is a more potent MS drug than dimethyl fumarate. The bigger question: is it better than the more costly ocrelizumab? Three possible answers: an official, a real and a right one. Which one do you prefer?the_MSBlog multiple-sclerosis-research.org/2022/08/haute-…

In simulated MS cohorts, lesion detection algorithms argue to be disease-modifying by detection more lesions, triggering early treatment switches and preventing disability. Nice feature or necessary add-on intervention? multiple-sclerosis-research.org/2022/10/pain-q…

linkedin.com/posts/joostsmo…

AHSCT for MS now available in the Netherlands for pwMS not responding to high efficacy therapies! nohttps://www.linkedin.com/posts/erasmus-mc-ms-center-erasms_stamceltransplantatie-voor-specifieke-groep-activity-7009461245594468352-uVty?utm_source=share&utm_medium=member_android

Ruth Dobson (UK) and Ide Smets (The Netherlands) explore the practicalities of therapeutic sequencing options in MS. Watch now: ow.ly/FTEX50OMQV5 #MedTwitter #Neurology #NeuroImmunology #MS #MultipleSclerosis #MedEd